CD HEALTH ALERT: Oral Agents for the Treatment of COVID-19 | Orange County California - Health Care Agency

CD News Alert

December 27, 2021

The Food and Drug Administration (FDA) last week issued emergency use authorizations (EUA) for the use of Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use), and Merck’s Molnupiravir, for treatment of COVID-19.

Patients eligible for treatment with Paxlovid or Molnupiravir are those who have mild-to-moderate COVID-19 and are at high risk for progression to severe disease.